Vital Role of Genetic Testing

Early detection is essential for optimally managing or treating infectious and genetic disease and, in that regard, molecular-based detection technologies have proven invaluable. One of the most desired tools for detecting disease remains a simple-to-operate, point-of-care system for looking at DNA and RNA accurately and in detail. This would fundamentally change the way disease becomes detected and even treated, but such technology so far remains essentially unavailable.

Bioterrorist threats such as Anthrax and the emergence of high-profile diseases like Severe Acute Respiratory Syndrome (SARS) and Highly Pathogenic Avian Influenza underscore a pressing need for rapid, portable detection methods simple enough for use anywhere, indoors or outdoors. DxNA has successfully developed such technology, an analytical system called GeneSTAT.